• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过竞争性酵母展示文库分选技术高效选择表位特异性抗体。

Highly efficient selection of epitope specific antibody through competitive yeast display library sorting.

机构信息

Protein Interactions Group, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD USA.

出版信息

MAbs. 2013 Jul-Aug;5(4):533-9. doi: 10.4161/mabs.25211. Epub 2013 May 29.

DOI:10.4161/mabs.25211
PMID:23765162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3906307/
Abstract

Combinatory antibody library display technologies have been invented and successfully implemented for the selection and engineering of therapeutic antibodies. Precise targeting of important epitopes on the protein of interest is essential for such isolated antibodies to serve as effective modulators of molecular interactions. We developed a strategy to efficiently isolate antibodies against a specific epitope on a target protein from a yeast display antibody library using dengue virus envelope protein domain III as a model target. A domain III mutant protein with a key mutation inside a cross-reactive neutralizing epitope was designed, expressed, and used in the competitive panning of a yeast display naïve antibody library. All the yeast display antibodies that bound to the wild type domain III but not to the mutant were selectively sorted and characterized. Two unique clones were identified and showed cross-reactive binding to envelope protein domain IIIs from different serotypes. Epitope mapping of one of the antibodies confirmed that its epitope overlapped with the intended neutralizing epitope. This novel approach has implications for many areas of research where the isolation of epitope-specific antibodies is desired, such as selecting antibodies against conserved epitope(s) of viral envelope proteins from a library containing high titer, high affinity non-neutralizing antibodies, and targeting unique epitopes on cancer-related proteins.

摘要

组合抗体文库展示技术已经被发明并成功应用于治疗性抗体的筛选和工程改造。为了使分离得到的抗体成为有效的分子相互作用调节剂,精确靶向目标蛋白上的重要表位至关重要。我们开发了一种策略,使用登革热病毒包膜蛋白结构域 III 作为模型靶标,从酵母展示抗体文库中高效分离针对靶蛋白特定表位的抗体。设计了一个关键突变位于交叉反应性中和表位内的结构域 III 突变蛋白,并在酵母展示原始抗体文库的竞争淘选中使用该蛋白。与野生型结构域 III 结合但不与突变型结合的所有酵母展示抗体都被选择性地分拣和表征。鉴定出两个独特的克隆,并显示与不同血清型的包膜蛋白结构域 III 发生交叉反应性结合。其中一种抗体的表位映射证实其表位与预期的中和表位重叠。这种新方法适用于许多需要分离表位特异性抗体的研究领域,例如从含有高滴度、高亲和力非中和抗体的文库中选择针对病毒包膜蛋白保守表位的抗体,以及针对癌症相关蛋白上的独特表位。

相似文献

1
Highly efficient selection of epitope specific antibody through competitive yeast display library sorting.通过竞争性酵母展示文库分选技术高效选择表位特异性抗体。
MAbs. 2013 Jul-Aug;5(4):533-9. doi: 10.4161/mabs.25211. Epub 2013 May 29.
2
An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies.一种工程化 N-糖基化登革热包膜蛋白结构域 III 促进了针对强效中和和最小增强抗体的表位定向选择。
ACS Infect Dis. 2024 Aug 9;10(8):2690-2704. doi: 10.1021/acsinfecdis.4c00058. Epub 2024 Jun 29.
3
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.工程化登革病毒结构域 III 蛋白在小鼠中引发交叉中和抗体反应。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.01023-18. Print 2018 Sep 15.
4
A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III.一种针对登革热病毒包膜结构域 III 的广谱中和性人源类胚系单克隆抗体。
PLoS Pathog. 2019 Jun 26;15(6):e1007836. doi: 10.1371/journal.ppat.1007836. eCollection 2019 Jun.
5
Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design.登革病毒包膜域 III 免疫诱导主要是交叉反应性、低中和抗体,定位于 AB 环:对登革热疫苗设计的影响。
J Gen Virol. 2013 Oct;94(Pt 10):2191-2201. doi: 10.1099/vir.0.055178-0. Epub 2013 Jul 12.
6
Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.利用酵母表面展示和噬菌体肽文库筛选技术对 SARS-CoV 刺突蛋白受体结合域的抗体结合位点进行作图。
Viral Immunol. 2009 Dec;22(6):407-15. doi: 10.1089/vim.2009.0046.
7
Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.通过噬菌体展示全面绘制登革病毒糖蛋白E结构域III上与广泛中和抗体4E11和4E5A结合的功能性表位。
Virology. 2015 Nov;485:371-82. doi: 10.1016/j.virol.2015.08.011. Epub 2015 Sep 2.
8
Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.登革病毒 E 亚基二聚化影响抗体功能和结构域聚焦。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00745-20.
9
Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.一种交叉反应性登革病毒中和抗体的结构与功能特征,该抗体识别隐蔽表位。
Structure. 2018 Jan 2;26(1):51-59.e4. doi: 10.1016/j.str.2017.11.017. Epub 2017 Dec 14.
10
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.针对登革2型病毒包膜蛋白结构域III的型别及亚复合物特异性中和抗体识别相邻表位。
J Virol. 2007 Dec;81(23):12816-26. doi: 10.1128/JVI.00432-07. Epub 2007 Sep 19.

引用本文的文献

1
Modular binder technology by NGS-aided, high-resolution selection in yeast of designed armadillo modules.基于 NGS 辅助的模块化结合技术,在酵母中通过高分辨率选择设计的鳞甲模块。
Proc Natl Acad Sci U S A. 2024 Jul 2;121(27):e2318198121. doi: 10.1073/pnas.2318198121. Epub 2024 Jun 25.
2
Epitope binning for multiple antibodies simultaneously using mammalian cell display and DNA sequencing.使用哺乳动物细胞展示和 DNA 测序同时进行多个抗体的表位分类。
Commun Biol. 2024 May 28;7(1):652. doi: 10.1038/s42003-024-06363-7.
3
Guidelines, Strategies, and Principles for the Directed Evolution of Cross-Reactive Antibodies Using Yeast Surface Display Technology.利用酵母表面展示技术进行交叉反应抗体定向进化的指南、策略和原则
Methods Mol Biol. 2022;2491:251-262. doi: 10.1007/978-1-0716-2285-8_14.
4
Engineered protein-small molecule conjugates empower selective enzyme inhibition.工程化蛋白-小分子缀合物赋予选择性酶抑制作用。
Cell Chem Biol. 2022 Feb 17;29(2):328-338.e4. doi: 10.1016/j.chembiol.2021.07.013. Epub 2021 Aug 6.
5
An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infections.一种针对 III 型分泌系统的抗体可诱导针对沙门氏菌和志贺氏菌感染的广泛保护。
PLoS Negl Trop Dis. 2021 Mar 12;15(3):e0009231. doi: 10.1371/journal.pntd.0009231. eCollection 2021 Mar.
6
Developing a cell-bound detection system for the screening of oxidase activity using the fluorescent peroxide sensor roGFP2-Orp1.开发一种基于细胞的检测系统,使用荧光过氧化物传感器 roGFP2-Orp1 筛选氧化酶活性。
Protein Eng Des Sel. 2020 Sep 14;33. doi: 10.1093/protein/gzaa019.
7
A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III.一种针对登革热病毒包膜结构域 III 的广谱中和性人源类胚系单克隆抗体。
PLoS Pathog. 2019 Jun 26;15(6):e1007836. doi: 10.1371/journal.ppat.1007836. eCollection 2019 Jun.
8
Capture and display of antibodies secreted by hybridoma cells enables fluorescent on-cell screening.杂交瘤细胞分泌抗体的捕获和显示可实现荧光细胞筛选。
MAbs. 2019 Apr;11(3):546-558. doi: 10.1080/19420862.2019.1574520. Epub 2019 Feb 22.
9
Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell.N-TIMP2变体的组合工程,其在细胞中选择性抑制MMP9和MMP14的功能。
Oncotarget. 2018 Aug 10;9(62):32036-32053. doi: 10.18632/oncotarget.25885.
10
Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.表位特异性亲和力成熟提高了强效蛋白酶抑制抗体的稳定性。
Biotechnol Bioeng. 2018 Nov;115(11):2673-2682. doi: 10.1002/bit.26814. Epub 2018 Sep 15.

本文引用的文献

1
High-resolution description of antibody heavy-chain repertoires in humans.人类抗体重链库的高分辨率描述。
PLoS One. 2011;6(8):e22365. doi: 10.1371/journal.pone.0022365. Epub 2011 Aug 4.
2
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.与HIV-1包膜糖蛋白结合的交叉反应性人IgM衍生单克隆抗体。
Viruses. 2010 Feb;2(2):547-565. doi: 10.3390/v2020547.
3
IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences.IMGT/V-QUEST:免疫球蛋白(IG)和T细胞受体(TR)核苷酸序列的IMGT标准化分析。
Cold Spring Harb Protoc. 2011 Jun 1;2011(6):695-715. doi: 10.1101/pdb.prot5633.
4
Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, Germany.下一代和生物类似单克隆抗体:在欧洲获得监管机构认可的必要考虑因素。2011 年 2 月 3 日至 4 日,德国弗莱堡。
MAbs. 2011 May-Jun;3(3):223-40. doi: 10.4161/mabs.3.3.15475. Epub 2011 May 1.
5
Development of yeast molecular display systems focused on therapeutic proteins, enzymes, and foods: functional analysis of proteins and its application to bioconversion.专注于治疗性蛋白质、酶和食品的酵母分子展示系统的开发:蛋白质的功能分析及其在生物转化中的应用。
Recent Pat Biotechnol. 2010 Nov;4(3):198-213. doi: 10.2174/187220810793611545.
6
New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.新型抗 CD20 单克隆抗体治疗 B 细胞淋巴瘤。
BioDrugs. 2011 Feb 1;25(1):13-25. doi: 10.2165/11539590-000000000-00000.
7
'Biosimilar' drugs poised to penetrate market.生物类似药有望打入市场。
Nature. 2010 Nov 4;468(7320):18-9. doi: 10.1038/468018a.
8
Development trends for human monoclonal antibody therapeutics.人源化单克隆抗体治疗药物的发展趋势。
Nat Rev Drug Discov. 2010 Oct;9(10):767-74. doi: 10.1038/nrd3229. Epub 2010 Sep 3.
9
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.抗登革病毒 2 型治疗性单克隆抗体的结构与功能分析。
J Virol. 2010 Sep;84(18):9227-39. doi: 10.1128/JVI.01087-10. Epub 2010 Jun 30.
10
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.开发能够中和登革热病毒 1 型同源和异源基因型的治疗性抗体。
PLoS Pathog. 2010 Apr 1;6(4):e1000823. doi: 10.1371/journal.ppat.1000823.